Using machine learning approaches to predict response to neoadjuvant chemotherapy in patients with triple-negative breast cancer

被引：0
|
作者：
Fisher, Timothy Byron
Li, Hongxiao
Ts, Rekha
Krishnamurthy, Jayashree
Bhattarai, Shristi
Janssen, Emiel A. M.
Kong, Jun
Aneja, Ritu
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P1-08-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-08-16
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [42] The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial-Mesenchymal Transition
    Zapperi, Stefano
    La Porta, Caterina A. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [43] Personalized chemotherapy selection for patients with triple-negative breast cancer using deep learning
    Yang, Xinyi
    Vladmirovich, Reshetov Iogr
    Georgievna, Poltavskaya Maria
    Sergeevna, Agakina Yulia
    He, Mingze
    Zeng, Zitong
    Qiang, Yinpeng
    Cao, Yu
    Sergeevich, Kulikov Timur
    FRONTIERS IN MEDICINE, 2024, 11
  • [44] A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators
    Zhang, Fanrong
    Huang, Minran
    Zhou, Huanhuan
    Chen, Kaiyan
    Jin, Jiaoyue
    Wu, Yingxue
    Ying, Lisha
    Ding, Xiaowen
    Su, Dan
    Zou, Dehong
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (12) : 3912 - 3919
  • [45] A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators
    Fanrong Zhang
    Minran Huang
    Huanhuan Zhou
    Kaiyan Chen
    Jiaoyue Jin
    Yingxue Wu
    Lisha Ying
    Xiaowen Ding
    Dan Su
    Dehong Zou
    Annals of Surgical Oncology, 2019, 26 : 3912 - 3919
  • [46] A nomogram to predict pathologic complete response of neoadjuvant chemotherapy in triple-negative breast cancer based on simple blood indicators
    Zhang, F.
    Huang, M.
    Zhou, H.
    Chen, K.
    Jin, J.
    Ding, X.
    Su, D.
    Zou, D.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Impact of Neoadjuvant Chemotherapy on Extent of Axillary Surgery in Patients With Triple-Negative Breast Cancer
    Connor, Carol S.
    Kimler, Bruce
    Mammen, Joshua M.
    McGinness, Marilee K.
    Wagner, Jamie L.
    Alsop, Samantha M.
    Ward, Claire
    Fabian, Carol
    Khan, Qamar
    Sharma, Priyanka
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 38 - 39
  • [48] Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients
    Cavallone, Luca
    Adriana, Aguilar-Mahecha
    Aldamry, Mohammed
    Lafleur, Josianne
    Cathy, Lan
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Ferrario, Cristiano
    Mihalciou, Catalin
    Roy, Josee-Anne
    Markus, Elisabeth
    Robidoux, Andre
    Pelmus, Manuela
    Aleynikova, Olga
    Discepola, Federico
    Basik, Mark
    CANCER RESEARCH, 2018, 78 (04)
  • [49] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Masuda, Hiroko
    Masuda, Norikazu
    Kodama, Yoshinori
    Ogawa, Masami
    Karita, Michiko
    Yamamura, Jun
    Tsukuda, Kazunori
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    Mano, Masayuki
    Nakamori, Shoji
    Tsujinaka, Toshimasa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 911 - 917
  • [50] A brief review of treatment options for neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Tiwari, Akash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 247 - 249
12345